BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12367739)

  • 1. Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy.
    Boulanger D; Baier R; Erfle V; Sutter G
    J Virol Methods; 2002 Oct; 106(1):141-51. PubMed ID: 12367739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene.
    Spehner D; Drillien R; Lecocq JP
    J Virol; 1990 Feb; 64(2):527-33. PubMed ID: 2153222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants.
    Kumar S; Boyle DB
    Arch Virol; 1990; 112(3-4):139-48. PubMed ID: 2165765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of recombinant fowlpox viruses as vectors for poultry vaccines.
    Boyle DB; Coupar BE
    Virus Res; 1988 Jun; 10(4):343-56. PubMed ID: 2842977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative genetic method to test essential vaccinia virus early genes.
    Kato SE; Greco FA; Damaso CR; Condit RC; Moussatché N
    J Virol Methods; 2004 Jan; 115(1):31-40. PubMed ID: 14656458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient method for generating poxvirus recombinants in the absence of selection.
    Rice AD; Gray SA; Li Y; Damon I; Moyer RW
    Viruses; 2011 Mar; 3(3):217-32. PubMed ID: 21494427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of unstable intermediate and stable forms of recombinant fowlpox virus.
    Nazerian K; Dhawale S
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2791-5. PubMed ID: 1658207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.
    Letellier C
    Arch Virol; 1993; 131(3-4):431-9. PubMed ID: 8394070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of novel fowlpox virus shuttle vectors.
    Du S; Liu C; Zhu Y; Wang Y; Ren D; Wang M; Tan P; Li X; Tian M; Zhang Y; Li J; Zhao F; Li C; Jin N
    Virus Res; 2015 Feb; 197():59-66. PubMed ID: 25529440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants.
    Prideaux CT; Kumar S; Boyle DB
    Virus Res; 1990 Apr; 16(1):43-57. PubMed ID: 2161593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the fowlpox virus genome region corresponding to the vaccinia virus D6 to A1 region: location of, and variation in, non-essential genes in poxviruses.
    Binns MM; Britton BS; Mason C; Boursnell ME
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():2873-81. PubMed ID: 2177083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of fowlpox virus recombination in the generation of recombinant vaccines.
    Parks RJ; Krell PJ; Derbyshire JB; Nagy E
    Virus Res; 1994 Jun; 32(3):283-97. PubMed ID: 8079511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selection of recombinant fowlpox virus coexpressing HIV-1 gag-gp120 and IL-6].
    Jiang WZ; Jin NY; Li ZJ; Zhang LS; Zou XH; Wang TD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):267-70. PubMed ID: 16261213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and identification of recombinant fowlpox virus for expressing haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain F48E8].
    Liu W; Wu Y; Jiang Y; Zhang R; Liu X
    Wei Sheng Wu Xue Bao; 1998 Oct; 38(5):359-64. PubMed ID: 12549399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the fowlpox virus thymidine kinase gene for the growth of FPV recombinants in cell culture.
    Scheiflinger F; Falkner FG; Dorner F
    Arch Virol; 1997; 142(12):2421-31. PubMed ID: 9672604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fowlpox virus vaccine vector with insertion sites in the terminal repeats: demonstration of its efficacy using the fusion gene of Newcastle disease virus.
    Boursnell ME; Green PF; Campbell JI; Deuter A; Peters RW; Tomley FM; Samson AC; Emmerson PT; Binns MM
    Vet Microbiol; 1990 Jun; 23(1-4):305-16. PubMed ID: 2169678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient expression assay for qualitative assessment of gene expression by fowlpox virus.
    Dhawale S; Beisel CE; Nazerian K
    Virus Genes; 1990 Feb; 3(3):213-20. PubMed ID: 2161157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus.
    Britton P; Green P; Kottier S; Mawditt KL; Penzes Z; Cavanagh D; Skinner MA
    J Gen Virol; 1996 May; 77 ( Pt 5)():963-7. PubMed ID: 8609493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of nonessential region on protective efficacy of recombinant fowlpox viruses].
    Sun L; Liu WJ; Chen SJ; Shi HY; Liu XF
    Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):359-62. PubMed ID: 15989226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.